Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

Selinexor

The fixed dose of selinexor is 60 mg (three 20 mg tablets)

DRUG

Placebo (for selinexor)

sugar tablet manufactured to mimic selinexor tablet

DRUG

carfilzomib

Administered as an IV infusion on Days 1, 2, 8, 9, 15 and 16 of each 4-week cycle for Cycles 1-13 and then on Days 1, 2, 15, and 16 for Cycles ≥ 14.

DRUG

Dexamethasone

Fixed oral dose of 20 mg will be given twice weekly (Days 1, 2, 8, 9, 15, 16, 22 and 23) in each cycle.

Trial Locations (2)

27518

Waverly Hematology, Cary

90069

James R. Berenson MD, Inc, West Hollywood

Sponsors
All Listed Sponsors
lead

Karyopharm Therapeutics Inc

INDUSTRY

NCT02628704 - Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma | Biotech Hunter | Biotech Hunter